Diabetes Publish Ahead of Print published online ahead of print August 26, 2008 DOI: 10.2337/db08-0878
β-Cell Proliferation, but not Neogenesis, Following 60% Partial Pancreatectomy is Impaired in the Absence of FoxM1
Amanda Ackermann Misfeldt, B.S2,4,
Robert H. Costa, PhD5, and
Maureen Gannon, PhD1,2,3,4
1Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee
2Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
3Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
4Program in Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
5Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois
Objective: This study was designed to determine whether the transcription factor FoxM1 was required for regeneration of β-cell mass via proliferation and/or neogenesis in the adult after 60% partial pancreatectomy (PPx).
Research Design and Methods: Adult mice with a pancreas-wide deletion of Foxm1 (Foxm1flox/flox;Pdx1-Cre [FoxM1 panc]) and their Control littermates (Foxm1flox/flox) were subjected to PPx or a Sham operation, after which islet expression of Foxm1 and several target genes, β-cell mass, proliferation, β-cell size, islet size, islet density, and Neurogenin3 expression were analyzed.
Results: In Control mice, PPx stimulated β-cell proliferation and neogenesis and up-regulated Foxm1 and several of its known targets (Plk1, Cenp-a, Birc5/Survivin, Ccnb1) in islets. Within 1 week post-PPx, Control mice underwent significant regeneration of β-cell mass, and average islet size within the regenerating lobe was similar to that after a sham operation. However, FoxM1 panc mice exhibited specific impairments in β-cell mass regeneration and islet growth after PPx, with reduced proliferation of and β-cells but no impairments in acinar or ductal cell proliferation. Interestingly, FoxM1 was not required for proliferation of β-cells within small endocrine cell clusters located in the regenerating portion of the pancreas, but was specifically required for proliferation of β-cells within larger islets. Additionally, FoxM1 was not required for β-cell neogenesis following PPx.
Conclusions: Our results indicate that FoxM1 is partially required for increased β-cell proliferation, but not β-cell neogenesis, stimulated by PPx. Furthermore, FoxM1 seems to be dispensable for proliferation of β-cells following neogenesis but is required for proliferation of pre-existing β-cells.
Correspondence:
maureen.gannon{at}vanderbilt.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2008 by the American Diabetes Association.
|
|
| |
|